BRADLEY MCCLURE: Open Payments
NPI 1790755916 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,783 in 171 payments from 20 companies in 2025. Trend: 2023 $121 · 2024 $3,194 · 2025 $2,783
Food & beverage: $2,779Education: $4
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $482 |
| Vanda Pharmaceuticals Inc. | 33 | $451 |
| Corium, LLC | 16 | $315 |
| Alkermes, Inc. | 17 | $315 |
| Axsome Therapeutics, Inc. | 9 | $224 |
| Otsuka America Pharmaceutical, Inc. | 15 | $211 |
| Teva Pharmaceuticals USA, Inc. | 5 | $97 |
| E.R. Squibb & Sons, L.L.C. | 5 | $93 |
| Bausch Health US, LLC | 4 | $81 |
| Collegium Pharmaceutical, Inc. | 4 | $78 |
Products named: VRAYLAR, FANAPT, Azstarys, REXULTI, ARISTADA, Auvelity, COBENFY, APLENZIN.
Industry payments across OK — which companies pay providers there.
